Financial Architects (New Jersey)’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $876K | Sell |
8,679
-128
| -1% | -$12.8K | 0.13% | 154 |
|
|
2023
Q1 | $810K | Sell |
8,807
-740
| -8% | -$64.6K | 0.13% | 158 |
|
|
2022
Q4 | $866K | Sell |
9,547
-127
| -1% | -$10.7K | 0.14% | 149 |
|
|
2022
Q3 | $735K | Buy |
+9,674
| New | +$802K | 0.13% | 153 |
|
|
2022
Q2 | – | Sell |
-9,863
| Closed | -$865K | – | 189 |
|
|
2022
Q1 | $865K | Sell |
9,863
-1,600
| -14% | -$139K | 0.12% | 155 |
|
|
2021
Q4 | $1M | Sell |
11,463
-673
| -6% | -$55.9K | 0.14% | 150 |
|
|
2021
Q3 | $992K | Sell |
12,136
-236
| -2% | -$21.2K | 0.14% | 139 |
|
|
2021
Q2 | $1.13M | Sell |
12,372
-474
| -4% | -$42.2K | 0.16% | 128 |
|
|
2021
Q1 | $1.1M | Sell |
12,846
-99
| -0.8% | -$8.88K | 0.17% | 122 |
|
|
2020
Q4 | $1.22M | Sell |
12,945
-275
| -2% | -$24K | 0.23% | 95 |
|
|
2020
Q3 | $1.15M | Sell |
13,220
-162
| -1% | -$14K | 0.25% | 89 |
|
|
2020
Q2 | $1.17M | Sell |
13,382
-105
| -0.8% | -$9.06K | 0.27% | 79 |
|
|
2020
Q1 | $1.11M | Sell |
13,487
-21
| -0.2% | -$1.87K | 0.3% | 74 |
|
|
2019
Q4 | $1.28M | Sell |
13,508
-332
| -2% | -$29.8K | 0.28% | 80 |
|
|
2019
Q3 | $1.2M | Sell |
13,840
-558
| -4% | -$50.1K | 0.28% | 76 |
|
|
2019
Q2 | $1.31M | Sell |
14,398
-2,107
| -13% | -$178K | 0.25% | 82 |
|
|
2019
Q1 | $1.42M | Sell |
16,505
-252
| -2% | -$20.2K | 0.24% | 81 |
|
|
2018
Q4 | $1.29M | Buy |
16,757
+140
| +0.8% | +$10.9K | 0.25% | 78 |
|
|
2018
Q3 | $1.28M | Sell |
16,617
-168
| -1% | -$12.4K | 0.21% | 89 |
|
|
2018
Q2 | $1.14M | Sell |
16,785
-1,479
| -8% | -$102K | 0.2% | 90 |
|
|
2018
Q1 | $1.32M | Sell |
18,264
-1,565
| -8% | -$119K | 0.26% | 69 |
|
|
2017
Q4 | $1.49M | Buy |
19,829
+41
| +0.2% | +$3.09K | 0.25% | 72 |
|
|
2017
Q3 | $1.52M | Sell |
19,788
-568
| -3% | -$42.9K | 0.27% | 69 |
|
|
2017
Q2 | $1.52M | Sell |
20,356
-3,463
| -15% | -$245K | 0.27% | 66 |
|
|
2017
Q1 | $1.58M | Sell |
23,819
-849
| -3% | -$56.6K | 0.28% | 68 |
|
|
2016
Q4 | $1.61M | Sell |
24,668
-1,290
| -5% | -$83.7K | 0.38% | 60 |
|
|
2016
Q3 | $1.84M | Sell |
25,958
-123
| -0.5% | -$8.96K | 0.49% | 42 |
|
|
2016
Q2 | $1.93M | Sell |
26,081
-47
| -0.2% | -$3.25K | 0.54% | 39 |
|
|
2016
Q1 | $1.7M | Sell |
26,128
-837
| -3% | -$56.9K | 0.61% | 38 |
|
|
2015
Q4 | $2.08M | Sell |
26,965
-905
| -3% | -$71.9K | 0.83% | 28 |
|
|
2015
Q3 | $2.3M | Buy |
27,870
+868
| +3% | +$77.3K | 0.97% | 25 |
|
|
2015
Q2 | $2.38M | Sell |
27,002
-1
| -0% | -$92 | 0.85% | 24 |
|
|
2015
Q1 | $2.39M | Buy |
27,003
+189
| +0.7% | +$16.8K | 0.92% | 22 |
|
|
2014
Q4 | $2.23M | Buy |
26,814
+84
| +0.3% | +$6.96K | 0.97% | 20 |
|
|
2014
Q3 | $2.25M | Sell |
26,730
-289
| -1% | -$23.4K | 1.1% | 18 |
|
|
2014
Q2 | $2.19M | Buy |
27,019
+55
| +0.2% | +$4.33K | 1.06% | 16 |
|
|
2014
Q1 | $2.05M | Hold |
26,964
| – | – | 1.23% | 16 |
|
|
2013
Q4 | $1.94M | Buy |
26,964
+1,511
| +6% | +$105K | 1.14% | 18 |
|
|
2013
Q3 | $1.75M | Buy |
25,453
+314
| +1% | +$20.8K | 1.13% | 16 |
|
|
2013
Q2 | $1.59M | Buy |
+25,139
| New | +$1.64M | 1.17% | 18 |
|
Other funds holding NVS
Financial Architects (New Jersey)'s NVS Position: Q2 2023 in Review
Financial Architects (New Jersey) reduced its Novartis (NVS) stake by 1.5% in Q2 2023, selling an estimated $12.8K and leaving 8,679 shares worth $876K. The position accounts for 0.13% of the portfolio, ranked #154.
Financial Architects (New Jersey) first reported a position in NVS in Q2 2013 and has held it in 40 quarters since. The position peaked at $2.39M in Q1 2015. 1,201 funds tracked by Wall St. Rank hold NVS as of Q2 2023.
- Financial Architects (New Jersey) held 8,679 shares of Novartis worth $876K as of Q2 2023.
- Financial Architects (New Jersey) sold 128 Novartis shares in Q2 2023, an estimated $12.8K.
- Novartis made up 0.13% of Financial Architects (New Jersey)'s portfolio in Q2 2023, its #154 holding.
- Financial Architects (New Jersey) first reported a position in Novartis in Q2 2013 and has held it in 40 quarters since.
- Financial Architects (New Jersey)'s Novartis position peaked at $2.39M in Q1 2015.
- 1,201 funds tracked by Wall St. Rank held Novartis as of Q2 2023.
Based on Financial Architects (New Jersey)'s 13F filing for Q2 2023, filed 10 Aug 2023.